Last $16.78 USD
Change Today +0.64 / 3.97%
Volume 3.4M
RGLS On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gregory J. Hannon Ph.D.

Member of Scientific Advisory Board, Regulus Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 2 different organizations across 3 different industries.

See Board Relationships
----

Background*

Dr. Gregory J. Hannon, Greg Ph. D Co-founded Galena Biopharma, Inc. Dr. Hannon served as an Advisor to Alnylam Pharmaceuticals. Dr. Hannon has been a Member of Scientific Advisory Board at Regulus Therapeutics Inc., since July 14, 2011. He served as a Member of Scientific Advisory Board at Galena Biopharma, Inc. since February 26, 2007. He is a Howard Hughes Investigator at Cold Spring Harbor Laboratory. His laboratory discovered the mechanism of RNAi in human cells. ...

Read Full Background

Corporate Headquarters*

3545 John Hopkins Court
San Diego, California 92121

United States

Phone: 858-202-6300
Fax: --

Board Members Memberships*

2012-Present
Director

Education*

PhD
Case Western Reserve University
BA
Case Western Reserve University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RGLS:US $16.78 USD +0.64

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ali Mortazavi Chief Executive and Director
Silence Therapeutics plc
70.0K GBP
Peter French B.Sc, M.Sc, Ph.D., MBAManaging Director, Chief Executive Officer and Director
Benitec Biopharma Limited
A$450.0K
Hans G. C. P. Schikan Chief Executive Officer and Member of Management Board
Prosensa Holding N.V.
--
Mark W. Schwartz Ph.D.Chief Executive Officer and President
Galena Biopharma, Inc.
$490.0K
Mark J. Murray Ph.D.Chief Executive Officer, President and Director
Tekmira Pharmaceuticals Corporation
$377.5K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGULUS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.